Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

The China-based trial enrolled 398 patients who were randomised to the ivonescimab and Keytruda arms at a one-to-one ratio.

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

At the Rajasthan Business Summit, ETHealthworld convened a discussion on "Reimagining Pharma and Healthcare: Innovations, ...

ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentationAdditionally, two posters on data from the pioneering use of tape stripping for biomarker ...

During HUAWEI CONNECT 2024, Huawei Cloud hosted a Summit themed 'One Step to Intelligence, One Leap to Excellence', gathering ...

The state recognized the nonprofit organization for honoring its history and ongoing contributions to the community and the ...

TIME's senior sports correspondent Sean Gregory tries his hand at several Olympic sports while learning from Olympians. Subscribe now to get unlimited access to TIME.com and more! Tidal action ...

With less than 50 days until voters take to the polls, second gentleman Doug Emhoff has been on the campaign trail supporting his wife, Vice President Kamala Harris, as she campaigns to be the ...

WHO and partners establish an access and allocation mechanism for mpox vaccines, treatments, tests - The Maravi Post ...